Roka Bioscience (ROKA) Reports Q2 Loss of $0.43
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Roka Bioscience (NASDAQ: ROKA) reported Q2 EPS of ($0.43), versus ($0.54) reported last year. Revenue for the quarter came in at $1.82 million, versus $1.47 million reported last year.
For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Tops Q3 EPS by 1c; Offers Light Q4 Outlook; Enters New Licensing Agreements
- Nu Skin Enterprises (NUS) Guides FY17 Revenue, EPS Below Views
- Applied DNA Sciences (APDN) Misses Q4 EPS by 1c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!